2022年12月14日

Altris AI,芝加哥AI平台眼保健专业人员战斗失明,已经得到100万美元的资金。投资轮由Runa资本(Chattermill最近支持)和联合旅程,制药公司Farmak,自流,Brinc有限,芝加哥大学布斯商学院和芝加哥布斯天使也参加了。按比例扩大计划Altris AI将使用投资规模AI-powered眼病理诊断的解决方案。“我们确信失明是可以预防因为它是可预测的。我们的核心动力是开发最准确的和强大的工具我们可以。我们很高兴有一群风投的支持,分享我们的价值观应用技术为全球医疗保健,”创始人兼首席执行官安德鲁Kuropyatnyk说Altris AI。“医疗是最具吸引力的AI的应用之一。最近机器学习的发展,海量数据聚集在这个行业将电力解决方案,协助医务人员日常。武装医生和临床医生以可靠和丰富的诊断是征服一个580亿美元的全球市场的第一步,”位于帕洛普通合伙人Michael Fanfant表示Runa资本。人工智能诊断工具,验光师来自乌克兰和总部位于芝加哥的公司是全球眼科市场580亿美元的建筑解决方案。 Over 1 billion people with preventable blindness conditions, such as glaucoma, late AMD and others struggle due to poor access to proper diagnostics and treatment. However, there is a shortage of optometrists worldwide as there are 331,000 available professionals while 14 million are needed to address the issues faced by people, claims the estimates by the World Economic Forum. AI can assist optometrists to be more efficient due to the technology’s ability to identify, localise, and quantify pathologies and pathological signs in almost every disease of the macula and retina. This is where Altris AI has developed a SaaS platform based on 5 million OCT scans that detected and interpreted over 100 pathologies and pathological signs, including age-related macular degeneration, glaucoma, and choroidal nevus. Altris AI provides an AI-powered medical image management platform, which is installed in over 30 clinics. The company also has a free educational mobile app with over 11,000 active users among ophthalmologists and optometrists. It has partnered with global OCT distributors and equipment manufacturers such as Topcon Healthcare, Optopol, and Huvitz. Background of Altris AI’s founders Altris AI was founded by Maria Znamenska and Andrey Kuropyatnyk. Maria is a full-time ophthalmologist, a Ph.D. in Ophthalmology, and the owner of the ophthalmic clinic in Kyiv, Ukraine. Andrey has an MBA from the University of Chicago Booth School of Business, and he is an experienced IT Management consultant with solid experience in this area. Currently, the team consists of 31 people comprising 93.6% from Ukraine. Only the Head of R&D is from Kazakhstan and the Head of Sales is from the UK. Also, 70% of the team are women and all the medical team who are responsible for the data preparation consists of women.